Multidisciplinary Association For Psychedelic Studies Funds MDMA-Assisted Therapy Trial For PTSD ...

The Multidisciplinary Association for Psychedelic Studies (MAPS) has put forward the first-ever application for 'psychedelic-assisted therapy' that could be approved early in 2024. The MDMA-based ...

The Food and Drug Administration (FDA) this week authorized a long-delayed clinical trial to test whether smoking marijuana ...

More than 300 veterans diagnosed with post-traumatic stress disorder will take part in a five-week study approved by the Food ...

The party drug MDMA could become the 'first psychedelic-assisted therapy' if it gets approval from the FDA in 2024. The Multidisciplinary Association for Psychedelic Studies (MAPS) has submitted ...

The conversation around psychedelics has shifted dramatically in recent years. Once stigmatized as counterculture drugs, psychedelics like psilocybin (found in ...

The Multidisciplinary Association for Psychedelic Studies, or MAPS for short, is conducting a series of tests to find out if the illegal drug MDMA, also known as Ecstasy, could be used to treat ...

2 For example, the non-profit Multidisciplinary Association for Psychedelic Studies (MAPS) has had great success in its two Phase III MDMA-assisted therapy studies for adults with post-traumatic ...

Rick Doblin launched the Multidisciplinary Association for Psychedelic Studies in 1986 to research and advocate for the use of LSD, magic mushrooms, and Ecstasy to treat mental illness. After more ...

MAPS — the Multidisciplinary Association for Psychedelic Studies — will initiate the short-term study of veterans who will smoke marijuana and report their reactions to the drug by using a ...